Does Alpha-Casozepine Help Anxious Dogs? What the Science Says

• Alpha-casozepine is a milk-derived peptide produced by breaking down a protein called alpha-S1 casein.

• It may support the brain's calming pathways, particularly those involving the neurotransmitter GABA, although its precise effects in dogs aren't fully understood.

• Research suggests modest anxiety-reducing benefits, with recent studies reporting improvements in stress-related behavior during veterinary examinations.

• It's not a sedative, so dogs can remain alert and responsive while taking it.

• Results vary between dogs, and the evidence is stronger for certain mild or situational stress responses than for severe anxiety disorders.

• It may take several days or weeks to evaluate its effects, depending on the situation and the individual dog.

• It's best used alongside behavioral support, rather than as a replacement for training, environmental changes, or prescribed anxiety medication when needed.

Alpha-casozepine is a bioactive peptide derived from alpha-S1 casein, one of the main proteins found in cow's milk.

A peptide is simply a short chain of amino acids, the building blocks of proteins. When milk proteins are broken down during digestion or specialized manufacturing processes, they can release smaller peptides with biological activity.

Alpha-casozepine is one of these compounds.

Researchers became interested in milk-derived peptides partly because young mammals often appear relaxed and sleepy after nursing. This observation helped inspire investigations into whether certain components of milk might influence neurological pathways associated with relaxation.

However, the calming effects of nursing involve many factors, including warmth, feeding, maternal contact, and physiological changes. We cannot assume that alpha-casozepine alone explains these effects.

The compound used in veterinary supplements is produced through controlled enzymatic processing of milk protein. This releases the peptide in a form intended to provide consistent amounts of the active ingredient.

Alpha-casozepine is found in products such as Zylkene, which is marketed for dogs and cats experiencing stressful situations.

Although it comes from milk, alpha-casozepine isn't equivalent to giving your dog ordinary cow's milk. Drinking milk won't reliably deliver the same peptide in the concentrations used in veterinary studies.

To understand alpha-casozepine, it helps to look at how the brain regulates anxiety.

Your dog's nervous system constantly balances signals that increase alertness with signals that reduce excessive activity.

When your dog encounters something frightening, such as fireworks or an unfamiliar visitor, the brain activates pathways involved in detecting threats and preparing the body to respond.

Heart rate may increase, muscles become tense, and attention shifts toward the perceived danger.

One of the brain's main systems for controlling this activity involves a neurotransmitter called gamma-aminobutyric acid, or GABA.

GABA is the brain's primary inhibitory neurotransmitter. In simple terms, it helps prevent nerve cells from becoming excessively active.

Think of the nervous system as a car. Some chemical messengers act as the accelerator, increasing activity and alertness. GABA provides part of the braking system, helping regulate that activity.

When GABA binds to certain receptors on nerve cells, it generally makes those cells less likely to fire.

This helps regulate functions including sleep, muscle tension, emotional responses, and anxiety.

Some prescription anxiety medications, particularly benzodiazepines, work by enhancing the effects of GABA at receptors called GABA-A receptors.

Alpha-casozepine appears to interact with related biological pathways.

Laboratory research suggests that alpha-casozepine may influence the GABA-A receptor system, potentially producing anxiety-reducing effects.

However, there is an important distinction between demonstrating activity in laboratory experiments and establishing exactly how an orally administered supplement works inside a dog's brain.

After a dog swallows alpha-casozepine, the peptide must pass through the digestive system. Questions remain about how much of the compound, or its biologically active breakdown products, reaches relevant targets and produces measurable neurological effects.

Researchers have proposed mechanisms involving GABA-A receptor modulation, but the precise process hasn't been conclusively established in dogs.

What matters clinically is whether these proposed effects translate into observable improvements in behavior.

That's where controlled veterinary studies become particularly valuable.

The evidence for alpha-casozepine has developed considerably over the past two decades.

Early research suggested potential benefits for dogs with anxiety disorders, but study limitations made it difficult to draw firm conclusions.

More recent randomized, placebo-controlled studies have provided additional evidence, particularly for stress associated with veterinary examinations.

One of the earliest clinical investigations was published by Beata and colleagues in the Journal of Veterinary Behavior in 2007.

The researchers recruited 38 dogs with anxiety-related disorders and compared alpha-casozepine with selegiline, a prescription medication.

Dogs received treatment for 56 days, and researchers assessed changes in anxiety-related behavior.

Both treatment groups showed improvements, with no statistically significant difference between their outcomes.

The researchers suggested that alpha-casozepine might provide a useful option alongside behavioral modification.

What does this mean for your dog?

The findings were promising, but they don't establish that alpha-casozepine works as well as prescription medication.

Because the study didn't include a placebo group, improvements could partly reflect other influences, including behavioral interventions, natural changes over time, or owner expectations.

Additionally, the study involved relatively few dogs.

It provided a useful starting point rather than definitive proof.

You can read the 2007 clinical study.

In 2017, a review published in Veterinary Evidence examined the available research on alpha-casozepine for canine anxiety.

The review concluded that evidence supporting medium- or long-term anxiety reduction was limited and generally of low quality.

At that time, there was insufficient evidence to demonstrate that giving alpha-casozepine shortly before a stressful event would reliably reduce anxiety.

The researchers emphasized the need for stronger clinical trials with better controls and more consistent outcome measures.

This distinction matters because a supplement can have a plausible biological mechanism without necessarily producing a clinically meaningful improvement.

Fortunately, additional research has since investigated the effects of alpha-casozepine during specific stressful experiences.

A randomized, placebo-controlled study published in The Veterinary Journal in 2024 investigated whether alpha-casozepine could reduce stress during veterinary examinations.

The study included 62 dogs, with 36 receiving casozepine and 26 receiving a placebo.

After two days of administration, researchers assessed behavioral stress scores, pulse rates, and stress-related hormones.

Dogs receiving casozepine showed significantly lower stress scores and lower average and maximum pulse rates than the placebo group.

However, both groups still showed signs of excitement during their examinations.

Interestingly, cortisol concentrations increased in the casozepine group, demonstrating that physiological stress responses don't always change in the same direction as observable behavior.

The researchers described the overall stress-reducing effect as weak.

For owners, this suggests alpha-casozepine may make veterinary visits somewhat easier for certain dogs, but it shouldn't be expected to eliminate fear.

Read the 2024 randomized clinical trial.

A more recent study by Puglisi and colleagues, published online with a 2025 DOI, examined alpha-casozepine in 20 privately owned dogs undergoing veterinary examinations.

This was a randomized, fully blinded, placebo-controlled crossover study.

That means each dog received both alpha-casozepine and placebo during different study periods, allowing researchers to compare the dog's responses under both conditions.

Dogs received alpha-casozepine at 15 mg/kg once daily for six days before their appointment.

The researchers found reductions in several behaviors associated with fear, including lowered body posture, ears, head, and tail.

Dogs also showed increased sniffing and exploration, behaviors that may indicate greater willingness to engage with their surroundings.

Veterinarians assigned lower stress scores to dogs receiving alpha-casozepine.

However, the researchers found no significant differences in heart rate, respiratory rate, heart rate variability, or body temperature.

These results suggest a potentially useful behavioral benefit, particularly for dogs experiencing mild to moderate situational anxiety.

Nevertheless, the sample was small, and the findings don't establish effectiveness for every type of canine anxiety.

Read the placebo-controlled study.

Taken together, these studies suggest that alpha-casozepine can produce modest improvements in certain anxiety-related behaviors.

The newer placebo-controlled trials strengthen the evidence compared with what was available in 2017, particularly for veterinary visit stress.

However, the research still has limitations. Most studies involve relatively small groups, different treatment durations, and different methods of measuring anxiety.

We also need larger trials involving dogs with well-defined anxiety disorders, rather than primarily examining short-term stress during veterinary visits.

The practical conclusion is that alpha-casozepine may be a helpful supportive supplement, but it isn't a proven treatment for severe canine anxiety.

Not all canine anxiety is the same. A dog who becomes nervous during a veterinary examination has a different problem from one who panics whenever their owner leaves home.

This matters because the effectiveness of any calming supplement depends partly on the underlying cause and severity of the anxiety.

Veterinary visits currently have some of the strongest direct clinical evidence supporting alpha-casozepine.

For dogs who become mildly nervous during examinations, the supplement may help reduce certain fear-related behaviors.

It could also be worth discussing with your veterinarian before predictable events such as travel, boarding, or household changes.

However, research specifically demonstrating benefits in these other situations remains limited.

Dogs with noise anxiety may tremble, hide, pace, vocalize, or attempt to escape during thunderstorms and fireworks.

Although alpha-casozepine is sometimes recommended for these situations, there is insufficient high-quality evidence demonstrating that it reliably treats canine noise phobias.

Dogs experiencing severe panic may require prescription medication and a structured behavior modification program.

Separation anxiety involves significant distress when a dog is separated from an attachment figure.

Affected dogs may vocalize, destroy objects, attempt to escape, or exhibit other distress-related behaviors.

Alpha-casozepine hasn't been adequately studied as a standalone treatment for separation anxiety.

It might provide additional support for some dogs, but treatment should focus on carefully managed departures, gradual desensitization, and veterinary-prescribed medication when appropriate.

One of the most common questions owners ask about calming supplements is how quickly they should expect results.

Unfortunately, alpha-casozepine doesn't have a precisely established onset of action in dogs.

The 2024 veterinary examination study found modest benefits after two days of administration, while the newer crossover study reported improvements after six days.

Earlier research investigated treatment over several weeks.

These findings suggest that some dogs may show improvements within days, although others may require a longer assessment period.

For predictable stressful events, some manufacturers recommend beginning administration several days beforehand, with longer preparation for certain situations.

However, these recommendations shouldn't be confused with proof that a specific treatment duration works for every dog.

When evaluating a supplement, I recommend looking for changes in meaningful behaviors rather than expecting an obvious transformation.

For example, does your dog recover more quickly after hearing an unfamiliar noise? Can they settle more easily after visitors arrive? Are they more willing to explore during veterinary appointments?

Keeping a simple behavior diary can help distinguish genuine progress from normal day-to-day variation.

Alpha-casozepine is generally considered well tolerated, and published canine studies haven't identified a consistent pattern of serious adverse effects.

Because it's derived from milk protein, owners sometimes worry about lactose intolerance.

However, alpha-casozepine itself is a peptide, not lactose. A supplement containing purified alpha-casozepine isn't equivalent to feeding a dog milk.

That said, dogs with known milk protein allergies may react to milk-derived ingredients, so these products should be avoided unless a veterinarian advises otherwise.

Occasional digestive upset or individual sensitivity is possible with nutritional supplements, even when most dogs tolerate them well.

It's also important to remember that supplements aren't evaluated to the same standards as approved prescription medications.

Product quality, ingredient concentrations, and supporting research can vary between manufacturers.

Alpha-casozepine may sometimes be incorporated into a broader veterinary anxiety management plan, including prescribed medication.

However, there is limited research examining its interactions with different veterinary psychiatric drugs.

If your dog already receives fluoxetine, clomipramine, trazodone, gabapentin, or another behavioral medication, discuss the supplement with your veterinarian before adding it.

Never discontinue prescribed medication simply because you're introducing a calming supplement.

Alpha-casozepine is one of several ingredients marketed to support relaxation in dogs. Others include L-theanine, L-tryptophan, and cannabidiol (CBD).

Although they're frequently grouped together as calming supplements, they work through different biological pathways, and the scientific evidence supporting each ingredient varies.

Alpha-casozepine is thought to influence GABA-related signaling in the brain, helping regulate excessive nervous system activity. Small clinical trials suggest it may provide modest benefits for dogs experiencing situational stress, particularly during veterinary examinations.

L-theanine is an amino acid naturally found in tea leaves. It may influence neurotransmitters involved in relaxation, including GABA, serotonin, and dopamine. Limited canine research suggests potential improvements in certain anxiety-related behaviors, although larger controlled studies are needed to establish its effectiveness.

L-tryptophan is an essential amino acid that the body uses to produce serotonin, a neurotransmitter involved in mood and emotional regulation. While this provides a plausible explanation for its potential calming effects, studies investigating L-tryptophan in dogs have produced mixed results. Much of the research also involves combination diets, making it difficult to determine the contribution of L-tryptophan alone.

CBD (cannabidiol) interacts with several signaling systems involved in stress responses, including pathways associated with the endocannabinoid system. Some studies have reported reductions in stress-related behaviors, but results remain inconsistent. CBD also raises additional considerations regarding product quality, liver enzyme changes, and potential interactions with medications.

There isn't enough reliable comparative research to establish which of these supplements is most effective for canine anxiety. Few studies have directly compared them under the same conditions, and differences in study design make meaningful comparisons difficult.

A supplement that appears helpful for one dog's mild situational anxiety may offer little benefit to another dog experiencing severe separation anxiety or noise phobia.

Rather than choosing a supplement based solely on its proposed mechanism, consider the type and severity of your dog's anxiety, the quality of the supporting research, and whether the ingredient can be safely incorporated into an appropriate behavioral management plan.

If you're considering alpha-casozepine, start by identifying the behavior you're hoping to improve.

A supplement is much easier to evaluate when you have a specific goal.

For example, rather than simply hoping your dog becomes calmer, you might aim to reduce trembling during veterinary visits or help them settle more quickly after visitors arrive.

Choose a reputable veterinary product with clearly stated ingredient concentrations and follow the manufacturer's weight-based instructions or your veterinarian's recommendation.

Avoid assuming that higher doses will produce better results. The doses investigated in clinical trials aren't necessarily appropriate for every commercial formulation or individual dog.

Most importantly, combine supplementation with practical anxiety management.

A nervous dog may benefit from predictable routines, a comfortable resting space, reward-based training, and gradual exposure to situations they find difficult.

For veterinary visits, this might involve practicing gentle handling at home, arranging quiet appointment times, or visiting the clinic for positive experiences that don't involve examinations.

Alpha-casozepine should support a dog's ability to cope, not replace the work of helping them feel safe.

If your dog's anxiety is severe, worsening, or affecting their quality of life, seek veterinary advice rather than relying on supplements alone. Pain, illness, and age-related cognitive changes can also contribute to anxious behavior.

Alpha-casozepine is an interesting example of how naturally occurring food-derived compounds may influence animal behavior.

Its proposed effects on GABA-related signaling provide a plausible biological explanation for its calming potential, while recent clinical studies offer encouraging evidence of modest improvements in anxiety-related behaviors.

However, the research doesn't support treating alpha-casozepine as a guaranteed solution for canine anxiety.

The strongest recent evidence concerns mild to moderate stress during veterinary examinations. We still need larger, well-designed studies to understand its effectiveness for noise phobias, separation anxiety, and other behavioral disorders.

For dogs experiencing mild or predictable stress, alpha-casozepine may be a reasonable supportive option to discuss with your veterinarian, particularly when combined with appropriate behavioral strategies.

Ultimately, the goal isn't simply to make an anxious dog appear quieter. It's to help them feel genuinely more comfortable and confident in situations they find difficult.

And that's the standard by which every calming supplement should be judged.